{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:34:27Z","timestamp":1793759667577,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008291","name":"University of Nebraska Medical Center College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130466","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:24:46Z","timestamp":1762388686000},"page":"130466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gallium Hematoporphyrin inhibits Mycobacteroides abscessus in vitro, including biofilm formation and stability"],"prefix":"10.1016","volume":"131","author":[{"given":"Seoung-ryoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Britigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabagaran","family":"Narayanasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2025.130466_bb0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/acs.molpharmaceut.7b01036","article-title":"In vitro efficacy of free and nanoparticle formulations of gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and mycobacterium abscessus and gallium biodistribution in mice","volume":"15","author":"Choi","year":"2018","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130466_bb0010","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/acsinfecdis.0c00113","article-title":"Gallium porphyrin and gallium nitrate synergistically inhibit mycobacterial species by targeting different aspects of Iron\/Heme metabolism","volume":"6","author":"Choi","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130466_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8091380","article-title":"Non-tuberculous mycobacteria: molecular and physiological bases of virulence and adaptation to ecological niches","volume":"8","author":"Pereira","year":"2020","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130466_bb0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/BF02111489","article-title":"Mycobacterial taxonomy","volume":"13","author":"Shinnick","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130466_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102305","article-title":"Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodology","volume":"139","author":"Mercaldo","year":"2023","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130466_bb0030","article-title":"Extrapulmonary nontuberculous mycobacterial infections: a guide for the general physician","volume":"24","author":"Malhotra","year":"2024","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.bmcl.2025.130466_bb0035","doi-asserted-by":"crossref","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","article-title":"Treatment for non-tuberculous mycobacteria: challenges and prospects","volume":"15","author":"Conyers","year":"2024","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130466_bb0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01038-2018","article-title":"The second recurrence of Mycobacterium avium complex lung disease after successful treatment for first recurrence","volume":"53","author":"Kwon","year":"2019","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130466_bb0045","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/AAC.04577-14","article-title":"Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease","volume":"59","author":"Lee","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130466_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01088-22","article-title":"Antibiotic maintenance and redevelopment of nontuberculous mycobacteria pulmonary disease after treatment of Mycobacterium avium complex pulmonary disease","volume":"10","author":"Zo","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130466_bb0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0031-6997(24)01383-8","article-title":"Mechanisms of therapeutic activity for gallium","volume":"50","author":"Bernstein","year":"1998","journal-title":"Pharmacol Rev"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130466_bb0060","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.bbamcr.2016.04.027","article-title":"Gallium and its competing roles with iron in biological systems","volume":"1863","author":"Chitambar","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130466_bb0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.coph.2013.07.001","article-title":"Gallium-based anti-infectives: targeting microbial iron-uptake mechanisms","volume":"13","author":"Kelson","year":"2013","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130466_bb0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2958.1999.01175.x","article-title":"Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem\/Hb uptake systems of pathogenic bacteria","volume":"31","author":"Stojiljkovic","year":"1999","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130466_bb0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijantimicag.2004.06.008","article-title":"Porphyrin-based compounds exert antibacterial action against the sexually transmitted pathogens Neisseria gonorrhoeae and Haemophilus ducreyi","volume":"24","author":"Bozja","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130466_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00443-19","article-title":"Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production","volume":"4","author":"Choi","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.bmcl.2025.130466_bb0085","first-page":"6","article-title":"Heme biosynthesis is coupled to electron transport chains for energy generation","volume":"1-6","author":"Moebius","year":"2010","journal-title":"Proc Natl Acad Sci U S A, Early Ed"},{"issue":"17","key":"10.1016\/j.bmcl.2025.130466_bb0090","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.jmb.2016.03.018","article-title":"Heme synthesis and acquisition in bacterial pathogens","volume":"428","author":"Choby","year":"2016","journal-title":"J Mol Biol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130466_bb0095","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1128\/AAC.01472-15","article-title":"Antimicrobial activity of gallium Protoporphyrin IX against Acinetobacter baumannii strains displaying different antibiotic resistance phenotypes","volume":"59","author":"Arivett","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130466_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ph9010016","article-title":"Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates","volume":"9","author":"Chang","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130466_bb0105","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/acsinfecdis.1c00280","article-title":"Gallium porphyrin and gallium nitrate reduce the high vancomycin tolerance of MRSA biofilms by promoting extracellular DNA-dependent biofilm dispersion","volume":"7","author":"Xia","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130466_bb0110","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/acsinfecdis.9b00100","article-title":"Dual inhibition of Klebsiella pneumoniae and Pseudomonas aeruginosa Iron metabolism using gallium porphyrin and gallium nitrate","volume":"5","author":"Choi","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130466_bb0115","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1021\/acs.molpharmaceut.3c00223","article-title":"Combination therapy with gallium Protoporphyrin and gallium nitrate exhibits enhanced antimicrobial activity in vitro and in vivo against methicillin-resistant Staphylococcus aureus","volume":"20","author":"Choi","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2025.130466_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00280","article-title":"Deferiprone and gallium-Protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small Colony variants","volume":"7","author":"Richter","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130466_bb0125","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/acsinfecdis.3c00050","article-title":"Development of gallium(III) as an antimicrobial drug targeting pathophysiologic Iron metabolism of human pathogens","volume":"9","author":"Scott","year":"2023","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130466_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128645","article-title":"Synthesis and in vitro analysis of novel gallium tetrakis(4-methoxyphenyl)porphyrin and its long-acting nanoparticle as a potent antimycobacterial agent","volume":"62","author":"Choi","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130466_bb0135","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1021\/acsinfecdis.4c00639","article-title":"Efficacy and possible mechanism(s) of action of gallium Tetraphenylporphyrin nanoparticles against HIV-TB coinfection in an in vitro granuloma structure model","volume":"10","author":"Choi","year":"2024","journal-title":"ACS Infect Dis"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130466_bb0140","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.bmcl.2016.02.087","article-title":"Development of potential broad spectrum antimicrobials using C-symmetric 9-fluorenone alkyl amine","volume":"26","author":"Choi","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130466_bb0145","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0957-4166(02)00240-9","article-title":"Asymmetric Michael Addition Reactions Using a Chiral La\u2013Na Aminodiolate Catalyst","volume":"Vol. 13","author":"Prabagaran","year":"2002","journal-title":"Tetrahedron Asymmetry"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130466_bb0150","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/acsinfecdis.0c00113","article-title":"Gallium porphyrin and gallium nitrate synergistically inhibit mycobacterial species by targeting different aspects of Iron\/Heme metabolism","volume":"6","author":"Choi","year":"2020","journal-title":"ACS Infectious Diseases"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130466_bb0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/JB.01388-06","article-title":"Heme concentration dependence and metalloporphyrin inhibition of the system I and II cytochrome c assembly pathways","volume":"189","author":"Richard-Fogal","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bmcl.2025.130466_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00012","article-title":"Gallium-Protoporphyrin IX inhibits Pseudomonas aeruginosa growth by targeting cytochromes","volume":"7","author":"Hijazi","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmcl.2025.130466_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00316","article-title":"Antimicrobial activity of gallium compounds on ESKAPE pathogens","volume":"8","author":"Hijazi","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130466_bb0170","first-page":"2663","article-title":"In vivo production of catalase containing haem analogues","volume":"277","author":"Brugna","year":"2010","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130466_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/mmi.15286","article-title":"Antioxidants are ineffective at quenching reactive oxygen species inside bacteria and should not be used to diagnose oxidative stress","volume":"122","author":"Korshunov","year":"2024","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130466_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01782-17","article-title":"Mycobacterium abscessus smooth and rough Morphotypes form antimicrobial-tolerant biofilm phenotypes but are killed by acetic acid","volume":"62","author":"Clary","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:35:17Z","timestamp":1780914917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S0960894X25003750"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130466","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gallium Hematoporphyrin inhibits Mycobacteroides abscessus in vitro, including biofilm formation and stability","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130466"}}